Skip to main content
Log in

Placental transfer of etozolin and ozolinone during the first half of gestation in man

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

The placental transfer of etozolin and its pharmacologically active metabolite ozolinone was studied in 48 patients during the first (44 patients) and second (4 patients) trimester. 24 patients received a single oral dose of etozolin 400 mg 2–20 h prior to interruption of pregnancy by curettage or prostaglandin infusion. 24 other patients received 3 oral doses of etozolin 400 mg (11 patients) or 800 mg (13 patients) on 3 consecutive days, and pregnancy was terminated 2–10 h after the last dose. The fetal tissue/maternal serum and placental tissue/maternal serum ratios of etozolin and ozolinone were found to lie between 0.3 and 0.6. The serum levels were lower in pregnant than in non-pregnant patients. The low placental and fetal concentrations of etozolin and ozolinone suggest that these drugs may prove useful when a diuretic is indicated in the treatment of oedema and hypertension during pregnancy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Beermann B, Groschinsky-Grind M, Fahraeus L, Lindström B (1978) Placental transfer of furosemide. Clin Pharmacol Ther 24: 560–562

    Google Scholar 

  • Berkowitz RL (1980) Anti-hypertensive drugs in the pregnant patient. Obstet Gynecol Surv 35: 191–204

    Google Scholar 

  • Biamino G, Kopp H, Rudroff W, Schneider B (1979) Etozolin (Elkapin) in der Behandlung der Herzinsuffizienz. Med Klin 74: 624–630

    Google Scholar 

  • Franklin ER, Chausseaud LF, Taylor T (1977) The distribution of radioactivity in pregnant rats after repeated oral doses of the diuretic agent etozolin. Arzneim Forsch (Drug Res) 27: 1800–1803

    Google Scholar 

  • Gladigau V, Vollmer KO (1977) Beschreibung des pharmakokinetischen Verhaltens von Etozolin und dessen Hauptmetaboliten. Arzneim Forsch (Drug Res) 27: 1786–1799

    Google Scholar 

  • Goossens N, Marshall M (1981) Beeinflussung des Blutgerinnungs-und Fibrinolysesystems und klinischer Parameter durch Etozolin. Med Welt 32: 47–53

    Google Scholar 

  • Hengy H, Vollmer KO, Gladigau V, Kölle EU (1980) Assay of etozolin and its main metabolite, ozolinone, in plasma by high performance liquid chromatography. Arzneim Forsch (Drug Res) 30: 1788–1790

    Google Scholar 

  • Herrmann M, Wiegleb J, Leuschner F (1977) Toxikologische Untersuchungen mit Etozolin. Arzneim Forsch (Drug Res) 27: 1758–1767

    Google Scholar 

  • Kelly JV (1977) Drugs used in the management of toxemia of pregnancy. Clin Obstet Gynecol 20: 395–410

    Google Scholar 

  • Knauf H, Hasenfuss G, Wais U, Schollmeyer P, Mutschler E (1980) Independence of etozolin elimination of kidney function. Arzneim Forsch (Drug Res) 30: 1791–1793

    Google Scholar 

  • Ivan E, Liddiard C, Nau H (1980) Placental transfer of etozolin and ozolinone after single and repeated doses. World Conference on Clinical Pharmacology and Therapeutics, London, poster abstract 614

  • Levy G, Procknal JA, Garettson LK (1975) Distribution of salicylate between neonatal and maternal serum at diffusion equilibrium. Clin Pharmacol Ther 18: 210–214

    Google Scholar 

  • Liddiard C, Nau H (1981) Determination of etozolin and ozolinone in human plasma and tissues by reversed-phase high-performance liquid chromatography. J Chromatogr 225: 504–508

    Google Scholar 

  • Merzweiler GA, Gladigau V (1978) Wirkungsvergleich zweier Diuretika — Etozolin und Furosemid — bei gesunden Probanden. Therapiewoche 28: 1–15

    Google Scholar 

  • Mirkin BL, Singh S (1976) Placental transfer of pharmacologically active molecules. In: Mirkin BL (ed) Perinatal pharmacology and therapeutics. Academic Press, New York, pp 1–69

    Google Scholar 

  • Mulley BA, Parr GD, Pau WK, Rye RM, Mould JJ, Siddle NC (1978) Placental transfer of chlorthalidone and its elimination in maternal milk. Eur J Clin Pharmacol 13: 129–131

    Google Scholar 

  • Nation RL (1980) Drug kinetics in childbirth. Clin Pharmacokinet 5: 340–364

    Google Scholar 

  • Nau H, Liddiard C, Bass R, Lange J, Haase V (1978) Der diaplazentare Übergang sowie der fetale Metabolismus von Pharmaka in der ersten Hälfte der menschlichen Schwangerschaft. In: Schnieders B, Stille G, Grosdanoff P (eds) Embryotoxikologische Probleme in der Arzneimittelforschung. Dietrich Reimer, Berlin, pp 89–96

    Google Scholar 

  • Nau H, Liddiard C (1978) Placental transfer of drugs during early human pregnancy. In: Neubert D, Merker HJ, Nau H, Langman J (eds) Role of pharmacokinetics in prenatal and perinatal toxicology. Georg Thieme, Stuttgart, Publishing Science Group, Littleton, MA, pp 465–481

    Google Scholar 

  • Nau H, Rating D, Häuser I, Jäger E, Koch S, Helge H (1980) Placental transfer and pharmacokinetics of primidone and metabolites in neonates and infants of epileptic mothers. Eur J Clin Pharmacol 18: 31–42

    Google Scholar 

  • Nöschel H, Bonnow A, Möller R, Estel Ch, Müller B (1972) Plazentapassage von Natriumsalizylat. Zentralbl Gynaekol 94: 437–442

    Google Scholar 

  • Pecorari D, Ragni N, Autera C (1969) Effetti sul neonato della somministrazione die furosemide alla modre durante il travaglio di parto. Acta Biol-Med 40: 3–11

    Google Scholar 

  • Reynolds F (1979) Transfer of drugs. In: Chamberlain G, Wilkinson A (eds) Placental transfer. Pitman Medical, London, pp 166–181

    Google Scholar 

  • Riva E, Farina P, Tognoni G, Bottino S, Orrico C, Pardi G (1978) Pharmacokinetics of furosemide in gestosis of pregnancy. Eur J Clin Pharmacol 14: 361–366

    Google Scholar 

  • Satzinger G (1977) Struktur-Aktivitäts-Betrachtungen zu Etozolin, einem neuartigen Diuretikum. Arzneim Forsch (Drug Res) 27: 1742–1754

    Google Scholar 

  • Satzinger G (1979) Neuere Entwicklungen in der Chemie der Diuretika. Dtsch Apoth Ztg 44: 1773–1781

    Google Scholar 

  • Satzinger G, Herrmann M, Vollmer KO, Merzweiler A (1978) Etozolin: A novel diuretic. In: Cragos EJ (ed) Diuretic agents, ACS Symposium Series 83, Am Chem Soc, Washington DC

    Google Scholar 

  • Vollmer KO, Hodenberg AV, Poisson A, Gladigau V, Hengy H (1977) Resorption, Verteilung, Metabolismus und Ausscheidung von 14C-Etozolin bei Ratte, Hund und Mensch. Arzneim Forsch (Drug Res) 27: 1767–1776

    Google Scholar 

  • Witter FR, King TM, Blake DA (1981) Adverse effects of cardiovascular drug therapy on the fetus and neonate. Obstet Gynecol 58: 100S-105S

    Google Scholar 

  • Wladimiroff JW (1975) Effect of furosemide on fetal urine production. Br J Obstet Gynaecol 82: 221–224

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nau, H., Steldinger, R. & Ivan, E. Placental transfer of etozolin and ozolinone during the first half of gestation in man. Eur J Clin Pharmacol 23, 253–260 (1982). https://doi.org/10.1007/BF00547564

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00547564

Key words

Navigation